|Published:||Jan 03, 2011 8:35 PM EST|
|Updated:||Jan 03, 2011 5:35 PM EST|
BOSTON (AP) - A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.
Boston scientists who invented the test and health care giant Johnson & Johnson announced Monday that they are joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.
Stray cancer cells in the blood mean that a tumor has spread or is likely to, many doctors believe. A test that can capture such cells has the potential to transform care for many types of cancer, especially breast, prostate, colon and lung.
Initially, doctors want to use the test to try to predict what treatments would be best for each patient's tumor and find out quickly if they are working.
"This is like a liquid biopsy" that avoids painful tissue sampling and may give a better way to monitor patients than periodic imaging scans, said Dr. Daniel Haber, chief of Massachusetts General Hospital's cancer center and one of the test's inventors.
Ultimately, the test may offer a way to screen for cancer besides the mammograms, colonoscopies and other less-than-ideal methods used now.
- Person of interest in Lehigh Acres killings not alone
- LCSO investigates North Ft. Myers homicide
- Suspect cuts Punta Gorda horse's mane
- Victim's parents ask for public's help in finding suspect
- Man who lost leg to propeller unable to reach settlement
- Five years fatality free: Florida set to break gator record
- Sun-N-Fun Lagoon opens for Collier schools' winter break
- Templeton Shootout drives millions into Naples economy
- House to tackle flood insurance rate hikes
- FWC reports 20th panther mortality for 2013